FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare
Syndicate content

Nexavar news from FiercePharma

Most Popular Nexavar story
Related Tags GlaxoSmithKline   Genentech   Eli Lilly   Trasylol
Tools

News

NICE rejects four cancer meds

August 7, 2008 — 10:16am ET | By Tracy Staton
The debate over costly oncology meds rages on in the U.K. as the National Institute for Health and Clinical Excellence rejected four high-tech drugs for advanced kidney cancer treatment: Read more...

Alimta, Nexavar look for ASCO boost

May 16, 2008 — 6:59am ET
As always, the American Society of Clinical Oncology's annual meeting is spawning tons of drug news. Only this year, the news is coming ahead of the conference itself, because ASCO released all the... Read more...

Alimta, Nexavar look for ASCO boost

May 16, 2008 — 6:59am ET
As always, the American Society of Clinical Oncology's annual meeting is spawning tons of drug news. Only this year, the news is coming ahead of the conference itself, because ASCO released all the... Read more...

ALSO NOTED: China accuses U.S. of obstructing heparin probe; GSK exec charges Mass. with demonizing pharma;

May 7, 2008 — 6:59am ET
> China continues to point fingers at the U.S. over the heparin investigation, saying the FDA refused to hand over details about patients who experienced severe allergic reactions to the blood... Read more...

Bayer loses Yasmin patent fight

March 4, 2008 — 7:59am ET
Bayer had the Yasmin rug pulled out from under it yesterday. A U.S. court voided the contraceptive's key patent, leading the German conglomerate to revise its 2008 profit expectations Read more...

Bayer lower 2008 expectations

February 29, 2008 — 7:59am ET
Call it Bad News Bayer. The German company reported a whopping 78 percent drop in profits for the fourth quarter and forecast 2008 sales growth at its lowest level in years. Though 2007 full-year... Read more...

Get more Nexavar coverage at:

FierceBiotech